Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Opportunities In Large Cap Growth And Small Cap
Article By:
Herbert Blank
Thursday, October 20, 2022 10:03 AM EDT
The third quarter was true "a tale of two eighths." It was a clear dichotomy starting with a bull market rally and ending with the bear mauling at the end of August and all of September.
Biotech Stocks Well-Positioned For The Fourth Quarter
Article By:
Tarun Chandra, CFA
Wednesday, October 12, 2022 1:12 AM EDT
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million
Article By:
ChinaBio® Today
Saturday, November 13, 2021 2:15 PM EDT
Shanghai Zai Lab announced two major in-licensings: a $615 million deal for two cancer drugs from Blueprint Medicines and a $187 million agreement for a psychiatric drug from Karuna Therapeutics.